STOCK TITAN

InflaRx (IFRX) director Brudnick reports shares and multiple stock option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

InflaRx N.V. director Richard Brudnick has filed an initial ownership report showing existing equity holdings. He directly holds 50,000 Ordinary Shares and multiple stock options over additional Ordinary Shares with exercise prices between $1.17 and $2.41 per share, expiring from 2029 through 2036. Most option grants are already fully vested and exercisable, while a January 2026 grant for 30,000 shares will vest in four equal quarterly installments of 7,500 shares, subject to continued service.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Brudnick Richard

(Last)(First)(Middle)
C/O INFLARX N.V.
WINZERLAER STREET 2

(Street)
JENA07745

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
InflaRx N.V. [ IFRX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares50,000D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (1)02/04/2029Ordinary Shares18,450$1.86D
Stock Option (Right to Buy) (2)01/04/2031Ordinary Shares20,000$1.86D
Stock Option (Right to Buy) (3)07/01/2031Ordinary Shares6,400$1.86D
Stock Option (Right to Buy) (4)01/11/2032Ordinary Shares30,000$1.86D
Stock Option (Right to Buy) (5)01/24/2033Ordinary Shares30,000$2.37D
Stock Option (Right to Buy) (6)01/05/2034Ordinary Shares30,000$1.79D
Stock Option (Right to Buy) (7)01/03/2035Ordinary Shares30,000$2.41D
Stock Option (Right to Buy) (8)01/06/2036Ordinary Shares30,000$1.17D
Explanation of Responses:
1. This option was granted on February 4, 2019 and is fully vested and exercisable as of the date hereof.
2. This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.
3. This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.
4. This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.
5. This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
6. This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
7. This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
8. This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 7,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
Remarks:
Exhibit List - Exhibit 24.1 Power of Attorney
/s/ Christian Schmid, Attorney-in-Fact03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)
Inflarx

NASDAQ:IFRX

View IFRX Stock Overview

IFRX Rankings

IFRX Latest News

IFRX Latest SEC Filings

IFRX Stock Data

61.65M
63.42M
Biotechnology
Healthcare
Link
Germany
Jena